2 completed, 1 recruiting. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Recruiting 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Inh: new trials by email Literature Review of Inh trials Research Report on Inh
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV Rifapentine, Isoniazid, Dolutegravir - Tuberculosis | Phase 1 / Phase 2 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 144 | 2026-09-28 | 2026-11-02 |
| Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines BCG Vaccine USP, Isoniazid, Rifampin - Tuberculosis | Phase 1 | Completed | Fred Hutchinson Cancer Center | 20 | 2022-12-06 | 2025-12-16 |
| Tuberculosis Clinical Trials Consortium Study 35 Rifapentine, Isoniazid - Latent Tuberculosis | Phase 1 / Phase 2 | Completed | Centers for Disease Control and Prevention | 69 | 2019-11-12 | 2026-07-24 |
Latent Tuberculosis (2) · Tuberculosis (2)
Centers for Disease Control and Prevention (1) · Fred Hutchinson Cancer Center (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
Botswana (1) · Haiti (1) · Kenya (1) · South Africa (1) · Thailand (1) · Uganda (1) · United States (1) · Zimbabwe (1)
Anneke Hesseling, MD (1) · Avy Violari, MD (1) · James Kublin, MD, MPH (1) · Mark Cotton, MD (1)